Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Diagnosing Atrial Fibrillation in 30 Seconds

Diagnosing Atrial Fibrillation in 30 Seconds

An interview with Glyn Barnes, Marketing Director for AliveCor, about Kardia Mobile and the Kardia Band, the FDA approved devices which can provide a diagnostic quality ECG reading in 30 seconds.

By AvectorImage Credit: Avector / Shutterstock

Why is it important to monitor your heartbeat regularly if you think you may have Atrial Fibrillation (AFib)?

If a doctor or nurse suspects that you may be suffering from atrial fibrillation or AFib, you will typically undergo two tests. Firstly, a simple pulse check which looks for an irregular heartbeat. If this is found to be positive, a patient may undergo a 12 lead ECG and then be given a 24 hour ECG monitor to wear at home.

A healthy ECG has a particular shape, denoted by the letters PQRST. The P wave is a small bump at the start of the trace. Typically, in a patient with AFib, this wave is missing.

A missing P wave, combined with an irregular heartbeat, is a strong indication that AFib is present. Doctors also use a scoring system to test how likely you are to have the condition.

Irregular electrical pulses in the upper chambers of the heart (atria) are characteristic of AFib and they prevent the heart from contracting properly. This can cause blood to pool in these chambers, which in turn increases the risk of clot formation.

If these clots break away from the heart, they pass quickly into the connecting large blood vessels. From there, they can travel upwards and lodge in the narrower vessels of the brain. This causes ischemia (a lack of oxygen to the tissue) and thus a stroke.

Strokes of this magnitude can be debilitating for patients, who often fail to make a full recovery assuming they survive the initial event.

Hence, monitoring your heartbeat regularly is highly important if you have (or are at risk of) AFib.

What is Kardia Mobile, and how does it work?

Kardia Mobile is a miniature clinical-grade ECG device that can be used to monitor the electrical activity of the heart and it works with most smartphones and tablets. Typically, an ECG involves attaching wires and electrodes to your body in a clinical setting.

The Kardia Mobile has only two of these electrodes, which are encompassed within a slimline device that’s smaller than a credit card.

When you feel your heart behaving unusually such as beating faster than normal or exhibiting palpitations, all you need do is activate the app on your phone and place fingers from each hand of the electrodes. The app then counts down 30 seconds after which, the device will have completed an ECG recording.

The results of your ECG are automatically analyzed, and if AFib is present, you will be notified by the app immediately.

You can then instantly email the results to your doctor or nurse. As the recording is of diagnostic quality, they can confirm the diagnosis of AFib upon receipt. You may then be given medication such as an anticoagulant, which will dramatically reduce your risk of stroke and could save your life.

One of the challenges with atrial fibrillation is that can be what’s known as paroxysmal, or intermittent. You may only have an event once a fortnight for example, which makes it incredibly difficult for doctors and nurses to make a diagnosis.

It is not very often that a patient has an episode of AFib whilst in the hospital at an appointment, so a diagnosis of AFib can take months or even years to make. During this time, you are five times more likely to have a stroke than a person of a similar age who doesn’t have AFib.

AFib is a huge health concern. It’s the most commonly diagnosed arrhythmia and places a heavy financial burden on health services. In England alone, the AFib costs the NHS £2.2bn per year, once you add in the after-care costs for patients who’ve had a stroke.

We’re not by any means replacing the ECG machines used in hospitals, as they provide a much greater amount of information than Kardia does. However, the Kardia Mobile is a fantastic low-cost device that enables patients to carry out an ECG anytime and anywhere.

You might be on the London underground, or in a supermarket, and you can take a real-time measurement of your heart’s activity, capturing events as they happen.

What is the Kardia Band, and how does it differ from Kardia Mobile?

The Kardia Band is a watch strap for the Apple Watch that allows you to take an ECG measurement. This displays on the screen of the watch as you use it. There’s a small, square sensor in the middle of the strap that’s double-sided.

When you need to take an ECG measurement, you place your right thumb on the top sensor and ensure that the bottom of the sensor is touching the skin on your left arm, as it should be when you are wearing the watch. From here, you will see a diagnostic quality ECG reading scrolling across the watch screen.

Like Kardia Mobile, a measurement using Kardia Band takes just 30 seconds and can be sent straight to your GP or cardiologist.

The added benefit of the Kardia Band is that it can be used to monitor your heart rate all day, and from this it makes predictions using AI about what your heart rate should be, relative to your current activity.

For example, if I’m busy and running between meetings in London, my heart rate should be higher than normal. However, if I’m sat at home having a cup of coffee and suddenly my heart rate spikes, the app will detect that, and prompt me to do an ECG there and then.

How is the technology useful for patients with conditions such as heart palpitations?

When Kardia Mobile and the Kardia Band were first launched, we focused on patients with AFib. However, it very quickly became apparent that the product could be used to monitor several other arrhythmias.

For example, when it comes to heart palpitations, we know that the vast majority of patients (80-85%) have nothing wrong with them. They are just experiencing normal palpitations that can be brought on by stress or too much coffee.

For these patients, being able to purchase a low-cost device such as the Kardia Mobile can give them piece of mind, while reducing the burden on the healthcare service.

They can then take the recordings to their GP, who, once confirmed ‘normal’ can reassure the patient and tell them that there is nothing to worry about. This can help to free up time for cardiologists and help to reduce waiting times for appointments.

By catshilaImage Credit: catshila / Shutterstock

It is clear that Kardia Mobile and the Kardia Band will help patients identify when their heartbeat is irregular, but how will it help clinicians?

More and more doctors are becoming interested in employing the Kardia Mobile in their clinics, and they’re also finding new uses for the devices. Some clinics are using the device to screen patients at routine appointments, whereas others are loaning it to patients so that they can capture the data they need to make a diagnosis.

The devices can also be used to monitor patients after surgery. For example, patients with AFib will sometimes undergo a procedure called ablation, where a wire is passed into the atria of the heart and, using heat or freezing, creates more direct channels of electrical activity. This helps the atria to contract properly and therefore blood to flow freely.

The procedure isn’t always successful, and it’s important to be able to detect this early. Even after a successful procedure, the symptoms of AFib may return with time. Some doctors now monitor their patients’ post ablation using KardaiMobileto check their progress.

A different and creative example of a hospital clinician using the device was an anesthetist. Sometimes, patients arriving in theatre are discovered to have an arrhythmia when hooked up to the monitor.

The case may then be canceled, causing unnecessary stress on the patient and wasting valuable operating time. So, this doctor now uses the Kardia Mobile to carry out ECG’s on every patient before they go down to theatre, saving time and resources.

Where can readers find more information?

https://www.alivecor.com/

About Glyn Barnes

Glyn Barnes - intervieweeGlyn has spent over twenty-five years working in the medical device industry holding senior roles in companies such as GE Healthcare and Spacelabs. With a passion for healthcare technology, he believes significant changes are underway with the provision of care in this country.

‘The NHS understands that we have to look at new technologies, empowering patients to be involved with their own care, and ultimately achieving efficiencies in the process. I joined AliveCor as I could see the company had developed exciting new devices to match this need and current product developments will further enhance our offering to the market.’

Tagged with:

About author

Related Articles